- Home
- VRSN vs TEVA Comparison
VRSN vs TEVA Comparison
Compare VRSN & TEVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VRSN
- TEVA
- Stock Information
- Founded
- VRSN 1995
- TEVA 1901
- Country
- VRSN United States
- TEVA Israel
- Employees
- VRSN N/A
- TEVA N/A
- Industry
- VRSN EDP Services
- TEVA Biotechnology: Pharmaceutical Preparations
- Sector
- VRSN Technology
- TEVA Health Care
- Exchange
- VRSN Nasdaq
- TEVA Nasdaq
- Market Cap
- VRSN 22.5B
- TEVA 18.4B
- IPO Year
- VRSN 1998
- TEVA N/A
- Fundamental
- Price
- VRSN $248.08
- TEVA $14.01
- Analyst Decision
- VRSN Strong Buy
- TEVA Strong Buy
- Analyst Count
- VRSN 2
- TEVA 6
- Target Price
- VRSN $262.50
- TEVA $24.00
- AVG Volume (30 Days)
- VRSN 914.2K
- TEVA 12.1M
- Earning Date
- VRSN 04-24-2025
- TEVA 05-07-2025
- Dividend Yield
- VRSN N/A
- TEVA N/A
- EPS Growth
- VRSN 1.27
- TEVA N/A
- EPS
- VRSN 8.00
- TEVA N/A
- Revenue
- VRSN $1,557,400,000.00
- TEVA $16,544,000,000.00
- Revenue This Year
- VRSN $6.40
- TEVA $5.31
- Revenue Next Year
- VRSN $1.15
- TEVA $1.18
- P/E Ratio
- VRSN $30.17
- TEVA N/A
- Revenue Growth
- VRSN 4.31
- TEVA 4.41
- 52 Week Low
- VRSN $167.05
- TEVA $12.47
- 52 Week High
- VRSN $258.67
- TEVA $22.80
- Technical
- Relative Strength Index (RSI)
- VRSN 54.60
- TEVA 43.94
- Support Level
- VRSN $239.40
- TEVA $13.04
- Resistance Level
- VRSN $251.20
- TEVA $13.74
- Average True Range (ATR)
- VRSN 7.87
- TEVA 0.77
- MACD
- VRSN -0.63
- TEVA 0.04
- Stochastic Oscillator
- VRSN 63.89
- TEVA 50.00
About VRSN VeriSign Inc.
Verisign is the sole authorized registry for several generic top-level domains, including the widely utilized .com and .net top-level domains. The company operates critical internet infrastructure to support the domain name system, including operating two of the world's 13 root servers that are used to route internet traffic. In 2018, the firm sold off its Security Services business, signalling a renewed focus on the core registry business.
About TEVA Teva Pharmaceutical Industries Limited
Teva Pharmaceutical Industries, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: the central nervous system with Copaxone, Ajovy, and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.